Please use this identifier to cite or link to this item:
|Title:||Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors||Authors:||Pehere, Ashok D.
Neilsen, Paul M.
Pedersen, Daniel Sejer
Sykes, Matthew J.
Callen, David F.
Abell, Andrew D.
|Keywords:||DRNTU::Engineering::Materials||Issue Date:||2013||Source:||Pehere, A. D., Pietsch, M., Gütschow, M., Neilsen, P. M., Pedersen, D. S., Nguyen, S., et al. (2013). Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors. Chemistry - A European Journal, 19(24), 7975-7981.||Series/Report no.:||Chemistry - a European journal||Abstract:||Peptide-derived protease inhibitors are an important class of compounds with the potential to treat a wide range of diseases. Herein, we describe the synthesis of a series of triazole-containing macrocyclic protease inhibitors pre-organized into a β-strand conformation and an evaluation of their activity against a panel of proteases. Acyclic azido–alkyne-based aldehydes are also evaluated for comparison. The macrocyclic peptidomimetics showed considerable activity towards calpain II, cathepsin L and S, and the 20S proteasome chymotrypsin-like activity. Some of the first examples of highly potent macrocyclic inhibitors of cathepsin S were identified. These adopt a well-defined β-strand geometry as shown by NMR spectroscopy, X-ray analysis, and molecular docking studies.||URI:||https://hdl.handle.net/10356/102746
|ISSN:||0947-6539||DOI:||10.1002/chem.201204260||Rights:||© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||MSE Journal Articles|
Updated on Mar 7, 2021
Updated on Mar 3, 2021
Page view(s) 50390
Updated on Aug 8, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.